Los Angeles Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29M | Sell |
64,937
-228,364
| -78% | -$106M | 0.11% | 156 |
|
|
2025
Q4 | $123M | Buy |
293,301
+257,829
| +727% | +$111M | 0.42% | 48 |
|
|
2025
Q3 | $13.9M | Buy |
35,472
+2,458
| +7% | +$1.03M | 0.05% | 236 |
|
|
2025
Q2 | $14.7M | Buy |
33,014
+7,291
| +28% | +$3.36M | 0.06% | 204 |
|
|
2025
Q1 | $12.5M | Buy |
25,723
+24,421
| +1,876% | +$11.4M | 0.06% | 206 |
|
|
2024
Q4 | $524K | Sell |
1,302
-17,425
| -93% | -$8.08M | ﹤0.01% | 802 |
|
|
2024
Q3 | $8.71M | Sell |
18,727
-45,969
| -71% | -$22.1M | 0.04% | 266 |
|
|
2024
Q2 | $30.3M | Sell |
64,696
-68,018
| -51% | -$29.5M | 0.11% | 146 |
|
|
2024
Q1 | $55.5M | Sell |
132,714
-257,160
| -66% | -$109M | 0.19% | 112 |
|
|
2023
Q4 | $159M | Sell |
389,874
-37,196
| -9% | -$13.7M | 0.59% | 33 |
|
|
2023
Q3 | $149M | Buy |
427,070
+842
| +0.2% | +$294K | 0.63% | 33 |
|
|
2023
Q2 | $150M | Sell |
426,228
-30,927
| -7% | -$10.4M | 0.6% | 34 |
|
|
2023
Q1 | $144M | Buy |
457,155
+10,144
| +2% | +$3.04M | 0.64% | 37 |
|
|
2022
Q4 | $129M | Buy |
447,011
+12,485
| +3% | +$3.81M | 0.63% | 41 |
|
|
2022
Q3 | $126M | Buy |
434,526
+97,060
| +29% | +$27.9M | 0.65% | 35 |
|
|
2022
Q2 | $95.1M | Sell |
337,466
-17,352
| -5% | -$4.64M | 0.47% | 47 |
|
|
2022
Q1 | $92.6M | Buy |
354,818
+52,813
| +17% | +$12.5M | 0.36% | 63 |
|
|
2021
Q4 | $66.3M | Buy |
302,005
+147,876
| +96% | +$28.8M | 0.25% | 92 |
|
|
2021
Q3 | $28M | Sell |
154,129
-15,228
| -9% | -$2.97M | 0.13% | 144 |
|
|
2021
Q2 | $34.1M | Sell |
169,357
-55,063
| -25% | -$11.5M | 0.15% | 139 |
|
|
2021
Q1 | $48.2M | Sell |
224,420
-82,644
| -27% | -$18.2M | 0.22% | 107 |
|
|
2020
Q4 | $72.6M | Sell |
307,064
-9,251
| -3% | -$2.12M | 0.31% | 68 |
|
|
2020
Q3 | $86.1M | Sell |
316,315
-16,597
| -5% | -$4.58M | 0.4% | 56 |
|
|
2020
Q2 | $96.6M | Buy |
332,912
+22,412
| +7% | +$6.08M | 0.47% | 44 |
|
|
2020
Q1 | $73.9M | Buy |
310,500
+4,390
| +1% | +$1.01M | 0.47% | 55 |
|
|
2019
Q4 | $67M | Sell |
306,110
-77,453
| -20% | -$15.7M | 0.33% | 81 |
|
|
2019
Q3 | $65M | Sell |
383,563
-50,423
| -12% | -$8.92M | 0.35% | 76 |
|
|
2019
Q2 | $79.6M | Sell |
433,986
-1,000
| -0.2% | -$175K | 0.43% | 59 |
|
|
2019
Q1 | $80M | Sell |
434,986
-7,000
| -2% | -$1.29M | 0.44% | 52 |
|
|
2018
Q4 | $73.2M | Sell |
441,986
-98,831
| -18% | -$17.1M | 0.45% | 56 |
|
|
2018
Q3 | $104M | Buy |
540,817
+1,659
| +0.3% | +$295K | 0.55% | 30 |
|
|
2018
Q2 | $91.6M | Buy |
539,158
+222,318
| +70% | +$34.5M | 0.51% | 31 |
|
|
2018
Q1 | $51.6M | Sell |
316,840
-2,680
| -0.8% | -$438K | 0.29% | 91 |
|
|
2017
Q4 | $47.9M | Buy |
319,520
+234,181
| +274% | +$34.7M | 0.26% | 96 |
|
|
2017
Q3 | $13M | Buy |
85,339
+81,727
| +2,263% | +$12.3M | 0.07% | 271 |
|
|
2017
Q2 | $465K | Buy |
+3,612
| New | +$435K | ﹤0.01% | 957 |
|
|
2017
Q1 | – | Sell |
-23,268
| Closed | -$1.71M | – | 1219 |
|
|
2016
Q4 | $1.71M | Sell |
23,268
-154,012
| -87% | -$12.5M | 0.01% | 575 |
|
|
2016
Q3 | $15.5M | Sell |
177,280
-11,821
| -6% | -$1.12M | 0.13% | 217 |
|
|
2016
Q2 | $16.3M | Buy |
+189,101
| New | +$16.3M | 0.14% | 190 |
|
|
2016
Q1 | – | Sell |
-2,114
| Closed | -$266K | – | 1199 |
|
|
2015
Q4 | $266K | Sell |
2,114
-2,322
| -52% | -$280K | ﹤0.01% | 1009 |
|
|
2015
Q3 | $462K | Sell |
4,436
-325,129
| -99% | -$41.8M | ﹤0.01% | 899 |
|
|
2015
Q2 | $40.7M | Buy |
329,565
+17,250
| +6% | +$2.17M | 0.38% | 73 |
|
|
2015
Q1 | $36.8M | Buy |
312,315
+309,801
| +12,323% | +$37.1M | 0.34% | 89 |
|
|
2014
Q4 | $299K | Hold |
2,514
| – | – | ﹤0.01% | 971 |
|
|
2014
Q3 | $282K | Hold |
2,514
| – | – | ﹤0.01% | 937 |
|
|
2014
Q2 | $238K | Sell |
2,514
-80,230
| -97% | -$5.63M | ﹤0.01% | 1097 |
|
|
2014
Q1 | $5.85M | Sell |
82,744
-31,110
| -27% | -$2.46M | 0.06% | 319 |
|
|
2013
Q4 | $8.46M | Sell |
113,854
-54,252
| -32% | -$3.78M | 0.09% | 255 |
|
|
2013
Q3 | $12.7M | Buy |
168,106
+157,393
| +1,469% | +$12.5M | 0.16% | 191 |
|
|
2013
Q2 | $858K | Buy |
+10,713
| New | +$789K | 0.01% | 712 |
|
Other funds holding VRTX
VCM
VPM
Los Angeles Capital Management's VRTX Position: Q1 2026 in Review
Los Angeles Capital Management reduced its Vertex Pharmaceuticals (VRTX) stake by 78% in Q1 2026, selling an estimated $106M and leaving 64,937 shares worth $29M. The position accounts for 0.11% of the portfolio, ranked #156.
Los Angeles Capital Management first reported a position in VRTX in Q2 2013 and has held it in 50 quarters since. The position peaked at $159M in Q4 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Los Angeles Capital Management held 64,937 shares of Vertex Pharmaceuticals worth $29M as of Q1 2026.
- Los Angeles Capital Management sold 228,364 Vertex Pharmaceuticals shares in Q1 2026, an estimated $106M.
- Vertex Pharmaceuticals made up 0.11% of Los Angeles Capital Management's portfolio in Q1 2026, its #156 holding.
- Los Angeles Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
- Los Angeles Capital Management's Vertex Pharmaceuticals position peaked at $159M in Q4 2023.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.